Peer-reviewedCC BY-NC-NDRegenerative therapy
Comprehensive regulatory and developmental landscape of cell–scaffold combination therapies for osteoarthritis
- 1Department of Bio-Pharmaceutical Industry, Dongguk University, Goyang-si, Gyeonggi-do, 10326, Republic of Korea
- 2Department of Food & Medical Products Regulatory Policy, Dongguk University, Goyang-si, Gyeonggi-do, 10326, Republic of Korea
- 3Department of Applied Life Science, Konkuk University, Chungju-si, Chungcheongbuk-do, 27478, Republic of Korea
Related
- Micro-fragmented adipose tissue reprogrammes the systemic molecular landscape of inflammatory knee osteoarthritis
- Unveiling the landscape of vancomycin in periprosthetic joint infections: a comprehensive bibliometric analysis
- India’s DNA synthesis landscape: regulatory frameworks, industry structure, and biosecurity gaps
- Mapping the subcellular pharmacokinetic-pharmacodynamic landscape: a systems-pharmacology framework for predicting combination therapies against intracellular bacterial infections
- USP25 stabilises GLI1 through K48‐linked deubiquitination within a reciprocal regulatory circuit in osteoarthritis models
BibTeX
@article{choi2026comprehensive,
title = {{Comprehensive regulatory and developmental landscape of cell–scaffold combination therapies for osteoarthritis}},
author = {Yunbin Choi and Seungyong Lee and Soobin Moon and Chaeeun Shin and Min Park and Mai Zakarya and Jihong Lim and Kyenghee Kwon},
journal = {Regenerative therapy},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13653442},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Comprehensive regulatory and developmental landscape of cell–scaffold combination therapies for osteoarthritis
AU - Yunbin Choi
AU - Seungyong Lee
AU - Soobin Moon
AU - Chaeeun Shin
AU - Min Park
AU - Mai Zakarya
AU - Jihong Lim
AU - Kyenghee Kwon
PY - 2026
DA - 2026/09/28
JO - Regenerative therapy
UR - https://europepmc.org/article/PMC/PMC13653442
SN - 2352-3204
ER -